My research is primarily focused on autophagy and selective autophagy (including nucleophagy and mitophagy) and their mechanistic roles in cell fate decisions, metabolic regulation, cancer biology, toxicology, and host–pathogen interactions. I have extensive expertise in dissecting PI3K/AKT/mTOR-regulated autophagy pathways, lysosomal dynamics, mitochondrial dysfunction, and crosstalk between autophagy and apoptosis using in-vitro and in-vivo models. My work integrates cell culture–based molecular biology, clinical biochemistry, insect and Drosophila models, natural bioactive compounds, and nanomaterial-based interventions, with a strong emphasis on mechanistic validation using biomarkers such as LC3, Beclin-1, ATG8, caspases, and BCL-2 family proteins.